Rankings
▼
Calendar
APGE Q1 2024 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$38M
Net Income
-$32M
EPS (Diluted)
$-0.64
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$32M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$824M
Total Liabilities
$22M
Stockholders' Equity
$801M
Cash & Equivalents
$485M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$38M
-$13M
-201.6%
Net Income
-$32M
-$13M
-156.2%
← FY 2024
All Quarters
Q2 2024 →